SECAUCUS, N.J., Aug. 28,
2024 /PRNewswire/ -- Quest Diagnostics Incorporated
(NYSE: DGX), a leader in diagnostic information services, announced
that Jim Davis, Chairman, CEO and
President, will speak on the company's strategy, performance and
the latest market developments and trends during a fireside chat at
the Morgan Stanley 22nd Annual Global Healthcare
Conference in New York City on
Friday, September 6, 2024, at
10:45 a.m. Eastern Time.
The fireside chat and Q&A session will be webcast live
during the conference and will be available on the company's
investor relations page which can be accessed at
ir.QuestDiagnostics.com. In addition, the archived webcast will be
available within 24 hours after the conclusion of the live event
and will remain available until October 6,
2024.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to
create a healthier world, one life at a time. We provide diagnostic
insights from the results of our laboratory testing to empower
people, physicians and organizations to take action to improve
health outcomes. Derived from one of the world's largest databases
of de-identifiable clinical lab results, Quest's diagnostic
insights reveal new avenues to identify and treat disease, inspire
healthy behaviors and improve healthcare management. Quest
Diagnostics annually serves one in three adult Americans and half
the physicians and hospitals in the
United States, and our nearly 50,000 employees understand
that, in the right hands and with the right context, our diagnostic
insights can inspire actions that transform lives and create a
healthier world. www.QuestDiagnostics.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-morgan-stanley-22nd-annual-global-healthcare-conference-302233363.html
SOURCE Quest Diagnostics